How certain medications help control appetite and insulin levels
Official title: Molecular mechanisms mediating metabolic benefits of glucagon-like peptide-1 receptor agonists
Funded at Vanderbilt University · NIH-10987062 · Data updated 2026-11-12
This study is looking at how a medication called liraglutide helps control hunger and insulin levels by understanding how it works in the brain and pancreas, which could lead to better treatments for diabetes and obesity.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | January 1, 2023 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $532,979 |
| NIH project number | 5R01DK132852-03 |
| Project ID | NIH-10987062 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with obesity or type 2 diabetes who are seeking better management options for their condition.
✕Less likely to help
Patients who do not have obesity or diabetes may not receive any benefit from this research.
What this research studies
This research investigates the molecular mechanisms by which glucagon-like peptide-1 receptor (GLP-1R) agonists, such as liraglutide, help regulate appetite and insulin secretion. The study focuses on understanding how these medications interact with key nutrient sensing pathways in the brain and pancreas, particularly the mechanistic Target of Rapamycin Complex-1 (mTORC1). By exploring these interactions, the research aims to uncover the biological processes that lead to reduced food intake and improved metabolic health, which could ultimately enhance treatment options for diabetes and obesity.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for managing obesity and diabetes by improving our understanding of how GLP-1R agonists work.
How similar studies have gone: Previous research has shown promising results with GLP-1R agonists in managing weight and insulin levels, indicating that this approach has potential for further success.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Ayala, Julio E — Vanderbilt University
- Study coordinator: Ayala, Julio E
Related research
Other NIH-funded projects on the same topics.
-
Understanding how peer norms around alcohol and HIV prevention affect adolescents and young adults in rural Uganda
This project studies how what young people think their peers do or approve of influences drinking and HIV prevention behaviors in rural Uganda, with the goal of improving health outcomes.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Targeted gene silencing in the brain using siRNA helpers
This grant tests a new way to turn off specific brain genes in particular CNS cell types using siRNA conjugates to help understand brain biology and disease.
-
RSELVES Study: How older couples influence daily life and function with Alzheimer’s risk
A study to understand how daily routines and support between older adults and their partners relate to the development of Alzheimer’s-related functional decline.
-
Molecular mechanisms of coat assembly and regulation in membrane trafficking
A research project seeks to understand how cellular coats organize and regulate the delivery of membrane-bound cargo, with a focus on proteins related to neurological diseases.
-
Synaptic nanostructure in neurodevelopmental disorders
This project aims to map the tiny architecture of brain synapses in native cells to understand how connections form and change in neurodevelopmental disorders.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.